%0 Journal Article
%T Bevacizumab or laser for aggressive posterior retinopathy of prematurity
%A Jose Maria Garcia Gonzalez
%A Laura Snyder
%A Mark Greenwald
%A Michael Blair
%A Michael Shapiro
%A Sarah Hilkert Rodriguez
%A Sidney Schechet
%J Archive of "Taiwan Journal of Ophthalmology".
%D 2018
%R 10.4103/tjo.tjo_69_18
%X The purpose of this study was to report the rate of reactivation and structural outcome, after the laser or bevacizumab treatment for aggressive posterior retinopathy of prematurity (APROP)
%K Aggressive posterior retinopathy of prematurity
%K bevacizumab
%K retinopathy of prematurity
%K treatment completion laser
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302568/